Publications by authors named "Andre Jefremow"

Claim this Profile
J
JAK inhibitors in the management of extra-intestinal manifestations in inflammatory bowel disease.
Fotios S Fousekis, André Jefremow, Konstantinos H Katsanos, Markus F Neurath, Raja Atreya

Therap Adv Gastroenterol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
Dominik Roth, Miriam M Düll, Ludwig J Horst, Aylin Lindemann, Xenia Malzer, André Jefremow

J Crohns Colitis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort.
Tiago de Castro, Sabrina Welland, Leonie Jochheim, Cathrine Leyh, Kateryna Shmanko, Andre Jefremow

Hepatol Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p21 Prevents the Exhaustion of CD4 T Cells Within the Antitumor Immune Response Against Colorectal Cancer.
Oana-Maria Thoma, Elisabeth Naschberger, Markéta Kubánková, Imen Larafa, Viktoria Kramer, André Jefremow

Gastroenterology· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Small Molecules in IBD: Current State and Future Perspectives.
André Jefremow, Markus F Neurath

Cells· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study.
Andrea Casadei-Gardini, Margherita Rimini, Masatoshi Kudo, Shigeo Shimose, Toshifumi Tada, Andre Jefremow

Liver Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study.
Sabrina Welland, Catherine Leyh, Fabian Finkelmeier, André Jefremow, Kateryna Shmanko

Liver Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New agents for immunosuppression.
André Jefremow, Markus F Neurath

Best Pract Res Clin Gastroenterol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR/Cas9 in Gastrointestinal Malignancies.
André Jefremow, Markus F Neurath, Maximilian J Waldner

Front Cell Dev Biol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Virus Manifestations in the Gastrointestinal Tract: Therapeutic Implications.
André Jefremow, Markus F Neurath

Visc Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All are Equal, Some are More Equal: Targeting IL 12 and 23 in IBD - A Clinical Perspective.
André Jefremow, Markus F Neurath

Immunotargets Ther· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticles in Gastrooncology.
André Jefremow, Markus F Neurath

Visc Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor fibroblast-derived epiregulin promotes growth of colitis-associated neoplasms through ERK.
Clemens Neufert, Christoph Becker, Özlem Türeci, Maximilian J Waldner, Ingo Backert, Andre Jefremow

J Clin Invest· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer.
Maximilian J Waldner, Stefan Wirtz, André Jefremow, Moritz Warntjen, Clemens Neufert

J Exp Med· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis